Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Гайдерова Лидия Александровна
Observed names:
L. A. Gaiderova,
L. A. Gayderova,
L.A. Gayderova,
Гайдерова Л. А.,
Гайдерова Лидия Александровна.,
Л. А. Гайдерова
show all 6
Institution:
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP)
Observed institution:
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (SCEEMP)
ORCID:
0000-0002-6176-5934
Observed ORCID:
0000-0002-6176-5934
OpenAlex ID:
A5070248109
General Characteristics of Adjuvants and Their Mechanism of Action (Part 1)
2020
·
N. A. Alpatova
, Zh. I. Avdeeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
12
PDF
Immune Response Induced by Immunisation with Antiviral Vaccines
2020
·
N. A. Alpatova
, Zh. I. Avdeeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
11
PDF
Особенности определения специфической активности биотехнологических лекарственных средств
2017
·
Н. А. Алпатова
, Л. А. Гайдерова
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
9
Implementation of the 3Rs Concept in Quality Control of Biologicals: Status and Prospects (Review)
2025
·
L. A. Gaiderova
, N. A. Alpatova
, et al.
·
Safety and Risk of Pharmacotherapy
·
8
Analysis of the mechanisms of development of the immune response in hepatitis B virus infection and ways to improve the effectiveness of vaccination
2021
·
Zh.I. Avdeeva
, N.A. Alpatova
, et al.
·
Immunologiya
·
7
PDF
Изучение принципов стандартизации фармакологической активности препаратов рекомбинантных эритропоэтинов
2016
·
А. К. Яковлев
, Л. А. Гайдерова
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
·
5
General characteristics of adjuvants and their mechanisms of action (part 2)
2021
·
N. А. Alpatova
, Zh. I. Avdeeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
4
PDF
Comparative Analysis of Dyes Used in the Assessment of Filgrastim Products Specific Activity by Biological in vitro Methods
2020
·
O. V. Golovinskaya
, M. L. Baykova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
4
PDF
Therapeutic Potential of Alpha-interferon Preparations During Socially-significant Human Diseases of Viral Etiology
2016
·
T. P. Ospelnikova
, E. M. Noseikina
, et al.
·
Journal of microbiology epidemiology immunobiology
·
4
PDF
Обзор методических подходов к оценке качества лекарственных средств на основе рекомбинантных интерферонов
2017
·
О. Б. Устинникова
, Л. А. Гайдерова
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
2
The Immunocompetent Cells Receptors Research Under Experimental Influenza Infection in Vitro
2015
·
A. N. Lisakov
, F. G. Nagieva
, et al.
·
Russian Journal of Infection and Immunity
·
2
PDF
Certification of a pharmacopoeial reference standard of lyophilized IgE-containing serum to ragweed pollen allergen
2026
·
L. V. Nevskaya
, N. E. Petrova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
PDF
Certification of a pharmacopoeial reference standard for potency testing of recombinant interferon α-2b
2024
·
L. A. Gaiderova
, Yu. N. Lebedeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
PDF
International standards for monoclonal antibodies for assessing the biological activity of medicines: A status update
2023
·
L. A. Gayderova
, N. A. Alpatova
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
PDF
Comparative evaluation of mono- and polyclonal antibodies used in identification of interferon alpha-2b products
2020
·
L. A. Gayderova
, Yu. N. Lebedeva
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
PDF
Разработка и аттестация отраслевого стандартного образца активности филграстима
2016
·
Е. В. Мотузова
, Н. А. Алпатова
, et al.
·
Biological Products Prevention Diagnosis Treatment
·
1
Validation of an in vitro biological method for filgrastim potency assessment
2026
·
L. A. Gaiderova
, M. L. Baykova
, et al.
·
Biological Products Prevention Diagnosis Treatment
Аттестация фармакопейного стандартного образца лиофилизированной IgE-содержащей сыворотки к аллергену пыльцы амброзии
2026
·
Невская Л. В.
, Петрова Н. Э.
, et al.
·
Biological Products Prevention Diagnosis Treatment
PDF
Expert Assessment of In Vitro Potency Assays for Monoclonal Antibody Preparations
2025
·
N. A. Alpatova
, O. V. Golovinskaya
, et al.
·
Ведомости Научного центра экспертизы средств медицинского применения
PDF
Potency evaluation of erythropoietin products: current status
2024
·
L. A. Gaiderova
, N. A. Alpatova
, et al.
·
Biological Products Prevention Diagnosis Treatment
PDF
Adverse Reactions to Intravenous Immunoglobulin Therapy: An Analysis of the Russian National Pharmacovigilance Database
2024
·
A. V. Nechaev
, S. A. Leshina
, et al.
·
Safety and Risk of Pharmacotherapy
PDF
Validation of a test procedure for determination of specific activity of human recombinant interferon beta (Infibeta®) using various cell/virus combinations
2021
·
Yu. N. Lebedeva
, N. A. Litvinova
, et al.
·
Biological Products Prevention Diagnosis Treatment
PDF
Общая Характеристика Адъювантов И Механизм Их Действия (часть 2)
2021
·
Алпатова Н. А.
, Авдеева Ж. И.
, et al.
·
Biological Products Prevention Diagnosis Treatment
Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
2020
·
M. L. Baykova
, I. M. Shcherbachenko
, et al.
·
Biological Products Prevention Diagnosis Treatment
PDF
Этапы стандартизации препаратов эритропоэтинов
2015
·
А. К. Яковлев
, Л. А. Гайдерова
, et al.
·
Biological Products Prevention Diagnosis Treatment
Show more works
View as search
Works count:
34
Citation count:
74
H-index:
5
I10-index:
2
Year
Topic
Type